Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
September 05 2023 - 8:30AM
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat rare and serious liver diseases, today
announced that Jerry Durso, President and Chief Executive Officer
of Intercept, and Andrew Saik, Chief Financial Officer of
Intercept, will participate in fireside chats and investor meetings
at the following upcoming investor conferences:
- The H.C. Wainwright 25th Annual Global Investment Conference,
for which the chat will be taking place on September 11th, 2023,
from 11:00-11:30am ET.
- The Baird Global Healthcare Conference, for which the chat will
be taking place on September 13th, 2023, from 3:10-3:40pm
ET.
The fireside chats can be accessed on the investor page of
Intercept’s website at http://ir.interceptpharma.com.
About Intercept Intercept is a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat rare and serious
liver diseases, including primary biliary cholangitis (PBC) and
severe alcohol-associated hepatitis (sAH). For more information,
please visit www.interceptpharma.com or connect with the
Company on LinkedIn, Threads, and X (formerly Twitter).
Contact For more information about
Intercept, please contact:
Investor inquiries: investors@interceptpharma.comMedia
inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2024 to May 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From May 2023 to May 2024